Fermenta Biotech to host investor meeting in Dahej on Oct 15

0 min read | Published on 12 Oct 2026, 09:52 PM |Updated on 12 Oct 2026, 09:52 PM

Reviewed by

Suketu GScanX News Team

Add as a preferred
source on Google

Key Highlights

Fermenta Biotech will hold a group investor meeting on October 15, 2026
The event will be conducted physically in Dahej, Gujarat
No unpublished price sensitive information will be discussed during the meeting

*this image is generated using AI for illustrative purposes only.

Fermenta Biotech Limited will participate in a group meeting with investors on October 15, 2026. The interaction is scheduled to take place in Dahej, Gujarat.

The company disclosed the details in a filing to stock exchanges on October 12, 2026. The meeting will be conducted in a physical mode. Fermenta stated that relevant press releases and investor presentations proposed for discussion are already available on its website and stock exchange platforms.

Meeting details and compliance

The company confirmed that no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction. This disclosure complies with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Detail	Information
Date	October 15, 2026
Type of meeting	Group meeting
Mode	Physical
Location	Dahej, Gujarat

Fermenta noted that changes to the schedule may occur due to exigencies on the part of the company or investors.

Historical Stock Returns for Fermenta Biotech

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.16%	-6.30%	+4.85%	+62.81%	+62.81%	+62.81%

How might the specific topics covered in the investor presentation influence Fermenta Biotech's stock volatility leading up to the October 15 meeting?

What are the key operational updates regarding the Dahej facility that investors are expected to scrutinize during the physical interaction?

Could the emphasis on strict UPSI compliance signal a shift in Fermenta Biotech's broader investor relations strategy for the upcoming fiscal year?

Fermenta Biotech

View Company Insights

View All News

Fermenta Biotech shifts one-to-one investor meeting to Oct 7

1 min read | Published on 21 Sept 2026, 09:14 PM |Updated on 01 Oct 2026, 06:32 PM

Reviewed by

Naman SScanX News Team

Add as a preferred
source on Google

Key Highlights

Fermenta Biotech rescheduled its one-to-one investor meeting to October 7, 2026
The event will be held physically in Mumbai, replacing the earlier October 5 date
No unpublished price-sensitive information (UPSI) will be discussed during the session

*this image is generated using AI for illustrative purposes only.

Fermenta Biotech has updated its schedule for a one-to-one physical meeting with investors, moving the event from October 5 to October 7, 2026, in Mumbai. The company confirmed that no unpublished price-sensitive information (UPSI) will be discussed during this interaction.

The engagement remains part of Fermenta Biotech’s ongoing efforts to maintain regular communication with its investor base. Officials from the company will participate in the session, which is scheduled to take place at a location in Mumbai. This update supersedes the earlier intimation regarding the September 24 date, the subsequent September 29 date, and the interim October 5 date.

Date	Type of meeting	Mode	Location
October 07, 2026	One-to-one meeting	Physical	Mumbai

The company noted that relevant press releases and investor presentations available on its website and stock exchange portals may be discussed during the interaction. Fermenta Biotech emphasized that changes to the schedule may occur due to exigencies on the part of the company or investors.

This disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The revised intimation was issued by Varadvinayak Khambete, Company Secretary and Head – Legal, on October 1, 2026.

Historical Stock Returns for Fermenta Biotech

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.16%	-6.30%	+4.85%	+62.81%	+62.81%	+62.81%

What underlying operational or strategic factors might have necessitated the multiple rescheduling of Fermenta Biotech's investor meetings since September?

How might the repeated changes in meeting dates influence institutional investor confidence in Fermenta Biotech's corporate governance and communication reliability?

Are there specific upcoming regulatory filings or earnings reports for Fermenta Biotech that could coincide with the revised October 7 meeting date?

Fermenta Biotech

View Company Insights

View All News